Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Re (RMAX) Cash & Equivalents (2016 - 2025)

Re (RMAX) has disclosed Cash & Equivalents for 14 consecutive years, with $118.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 22.89% to $118.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $118.7 million, a 22.89% increase, with the full-year FY2025 number at $118.7 million, up 22.89% from a year prior.
  • Cash & Equivalents was $118.7 million for Q4 2025 at Re, up from $107.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $126.3 million in Q4 2021 to a low of $66.1 million in Q2 2024.
  • A 5-year average of $101.1 million and a median of $99.7 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: plummeted 31.72% in 2024, then soared 42.76% in 2025.
  • Re's Cash & Equivalents stood at $126.3 million in 2021, then dropped by 13.94% to $108.7 million in 2022, then fell by 23.96% to $82.6 million in 2023, then grew by 16.94% to $96.6 million in 2024, then increased by 22.89% to $118.7 million in 2025.
  • Per Business Quant, the three most recent readings for RMAX's Cash & Equivalents are $118.7 million (Q4 2025), $107.5 million (Q3 2025), and $94.3 million (Q2 2025).